MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
about
MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis.The association between GGCX, miR-133 genetic polymorphisms and warfarin stable dosage in Han Chinese patients with mechanical heart valve replacement
P2860
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
@en
type
label
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
@en
prefLabel
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
@en
P2093
Carly Conran
De-Ke Jiang
Dong-Lin Ding
Guopeng Yu
Haitao Chen
Hexige Saiyin
Hongjie Yu
Hui-Xing Huang
Jielin Sun
P2860
P2888
P304
P356
10.1007/S13277-016-4897-1
P50
P577
2016-01-27T00:00:00Z
P6179
1041409160